期刊文献+

UV法测定替格瑞洛分散片的含量均匀度 被引量:2

Determination of Content Uniformity of Ticagrelor Dispersible Tablets by UV Method
下载PDF
导出
摘要 建立了UV法测定替格瑞洛分散片的含量均匀度。采用UV法对替格瑞洛分散片的含量均匀度进行了测定,以乙腈-水(体积比35∶65)为溶剂,检测波长为300 nm,检测质量浓度为15μg/mL。替格瑞洛质量浓度在3.0~25.0μg/mL范围内与吸光度线性关系良好(r=0.9999,n=8),样品在12 h内稳定,平均回收率为101.75%,RSD为0.92%(n=12);采用UV法测得3批样品的A+2.2S分别为5.04、1.57和3.92,含量均匀度均在合格范围内,A+2.2S≤15.0,且与HPLC法测定结果相比无明显差异。所建立的方法准确度高、快速、简便、经济、重现性好,可用于替格瑞洛分散片含量均匀度的测定。 To establish a UV method to determine the content uniformity of ticagrelor dispersible tablets.The content uniformity of ticagrelor dispersible tablets was determined by UV spectrophotometry method.Acetonitrile-water(35∶65,V/V)was used as the solvent,the detection wavelength was 300 nm,and the detection concentration was 15μg/mL.The mass concentration of ticagrelor has a good linear relationship with absorbance in the range of 3.0~25.0μg/mL(r=0.9999,n=8),and the sample was stable within 12 h.The average recovery rate was 101.75%,with a RSD of 0.92%(n=12).The A+2.2S of 3 batches of samples measured by UV method are 5.04,1.57 and 3.92 respectively.And the content uniformity is within the qualified range,A+2.2S≤150.There is no significant difference compared with the HPLC method.The established method is highly accurate,fast,simple,economical,and reproducible.It can be used for the determination of ticagrelor dispersible tablets content uniformity.
作者 张丽 李勇 王昆 张伟 Zhang Li;Li Yong;Wang Kun;Zhang Wei(School of Pharmaceutical Science&Yunnan Key Laboratory of Pharmacology for Natural Products,Kunming Medical University,Kunming 650500,China;Kunming Longjin Pharmaceutical Co.,Ltd.,Kunming 650503,China)
出处 《云南化工》 CAS 2022年第8期52-55,共4页 Yunnan Chemical Technology
基金 云南省科技厅2021年科技计划(202102AA310024)。
关键词 UV法 HPLC法 替格瑞洛分散片 含量均匀度 ultraviolet spectrophotometry high performance liquid chromatography ticagrelor dispersible tablets content uniformity
  • 相关文献

参考文献10

二级参考文献63

  • 1林晓辉,张雪原,陈琏,丁红婴.RP-HPLC测定甲睾酮片中甲睾酮的含量[J].广东药学,2005,15(6):15-16. 被引量:5
  • 2李家增.血管血栓性疾病的发病机制和防治[J].基础医学与临床,2006,26(6):561-565. 被引量:19
  • 3魏会宇,刘莹,张瑶纾.高效液相色谱测定阿司匹林、双嘧达莫双层片含量方法的建立[J].天津医科大学学报,2007,13(1):102-103. 被引量:6
  • 4王建青,赵宝泉.治疗血栓性疾病药物的研究进展[J].河北医学,2007,13(9):1167-1170. 被引量:10
  • 5杨晓伟,张君毅,易甫,等.替格瑞洛对急性冠状动脉综合征择期介入治疗患者近中期疗效观察[J].中华临床医师杂志:电子版,2013,7(19):8696.
  • 6Komosa A, Lesiak M, Siniawski A, et al.Significance of antiplatelet therapy in emergency myocardial infarction treatment[J].Postepy Kardiol Interwencyjnej , 2014, 10 (1):32.
  • 7Leonardi S, Camporotondo R, De Ferrari G, et a/.Efficacy versus safety: the dilemma of using novel platelet inhibi- tors for the treatment of patients with ischemic stroke and coronary artery disease[J].Ther Clin Risk Manag, 2014, 10:321.
  • 8Navarese EP, Buffon A, Kozinski M, et al.A critical over- view on ticagrelor in acute coronary syndromes[J].QJM, 2013,106(2) : 105.
  • 9Sinhal AR, Aylward PE.New antiplatelet agents and the role of platelet function testing in acute coronary syn- dromes[J].Clin Ther, 2013,35 (8) : 1 064.
  • 10Wijeyerame YD, Joshi R, Heptinstall S.Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromes[J].Expert Rev Clin Pharmacol, 2012,5 (3) : 257.

共引文献54

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部